Back to Browse Journals » Vascular Health and Risk Management » Volume 8

Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients

Authors Mat Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M

Published Date March 2012 Volume 2012:8 Pages 187—195


Received 1 December 2011, Accepted 8 February 2012, Published 20 March 2012

Zulfitri A Mat Daud1, Boniface Tubie2, Judy Adams2, Tracey Quainton2, Robert Osia2, Sharon Tubie2, Deepinder Kaur1, Pramod Khosla1, Marina Sheyman2
1Department of Nutrition and Food Science, Wayne State University, 2Great Lake Dialysis, LLC, Detroit, MI, USA

Purpose: Malnutrition and chronic inflammation in dialysis patients negatively impacts prognosis. However, intervening to correct this problem (through nutritional supplementation) is often hampered by poor compliance due to both medical and socioeconomic barriers. We have therefore performed a pilot study to investigate the technical feasibility of “directly observed treatment” of nutritional supplementation (protein and omega-3 fatty acids), administered during regular dialysis sessions. Secondary end points included observation of nutritional and inflammatory status of hypoalbuminemic patients undergoing hemodialysis.
Methods: Main inclusion criteria were serum albumin ≤ 3.9 g/dL (3 months prior to the study). Sixty-three eligible patients agreed to participate. Two intervention groups received 30 mL of a liquid protein supplement plus either 2.4 g omega-3 (1800 mg eicosapentaenoic acid + 600 mg docosahexaenoic acid) or a placebo, three times per week after their routine dialysis session for 6 months. Serum albumin, plasma lipids, and other indicators of nutritional and inflammatory status were measured.
Results: Directly observed nutritional supplementation resulted in a significant improvement in the low density lipoprotein cholesterol/high density lipoprotein cholesterol ratio in the omega-3 group as compared to the placebo group (P = 0.043). For the omega-3 group, serum albumin was also marginally higher after 6 months as compared to baseline (P = 0.07). The observed increase in C-reactive protein in the placebo group over 6 months was not apparent in the omega-3 group, although there was no significant difference between groups. Nuclear factor kappa B, malnutrition-inflammation score, normalized protein nitrogen appearance, body mass index, and hemoglobin were unaffected by the intervention.
Conclusion: “Directly observed treatment” with an omega-3 based supplement (as opposed to a pure protein supplement) showed beneficial effects on the lipid profile, and C-reactive protein levels. Further studies using a combination of outpatient and inpatient “directly observed treatment” of omega-3 based supplementation is warranted.

Keywords: protein and omega-3 supplementation, inflammation, nutritional status, hemodialysis

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients

Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P

Vascular Health and Risk Management 2013, 9:747-761

Published Date: 28 November 2013

Readers of this article also read:

Extramedullary plasmacytoma in the presence of multiple myeloma: clinical correlates and prognostic relevance

Chen HF, Wu TQ, Li ZY, Shen HS, Tang JQ, Fu WJ, Yuan ZG, Hou J

OncoTargets and Therapy 2012, 5:329-334

Published Date: 7 November 2012

Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency

Nakajima K, Oshida H, Muneyuki T, Kakei M

Core Evidence 2012, 7:77-91

Published Date: 19 July 2012

Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community-acquired pneumonia

Ugajin M, Yamaki K, Iwamura N, Yagi T, Asano T

International Journal of General Medicine 2012, 5:583-589

Published Date: 12 July 2012

The therapeutic potential of synthetic human atrial natriuretic peptide in nephrotic syndrome: a randomized controlled trial

Kanzaki M, Wada J, Kikumoto Y, Akagi S, Nakao K, Sugiyama H, Makino H

International Journal of Nephrology and Renovascular Disease 2012, 5:91-96

Published Date: 5 June 2012

Relating illness complexity to reimbursement in CKD patients

Bessette RW, Carter RL

International Journal of Nephrology and Renovascular Disease 2011, 4:121-130

Published Date: 19 September 2011

Renal artery stenosis in kidney transplants: assessment of the risk factors

Etemadi J, Rahbar K, Haghighi AN, Bagheri N, Falaknazi K, Ardalan MR, Ghabili K, Shoja MM

Vascular Health and Risk Management 2011, 7:503-507

Published Date: 10 August 2011

A PDA-based dietary self-monitoring intervention to reduce sodium intake in an in-center hemodialysis patient

Mary Ann Sevick, Roslyn A Stone, Matthew Novak, Beth Piraino, Linda Snetselaar, et al

Patient Preference and Adherence 2008, 2:177-184

Published Date: 2 July 2008